ritalin la methylphenidate hydrochloride capsule extended release

1 INDICATIONS AND USAGE Ritalin LA ® is indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD), in pediatric patients 6 to 12 years of age [see Clinical Studies ( 14 )] . Ritalin LA is a central nervous system (CNS) stimulant indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in pediatric patients 6 to 12 years of age ( 1 ).

novartis pharmaceuticals corporation

FDA Reported Adverse Reactions
`[1] fatigue` `[2] drug ineffective` `[3] nausea` `[4] dyspnoea` `[5] diarrhoea` `[6] pain` `[7] off label use` `[8] headache` `[9] dizziness` `[10] arthralgia`

6 years ago

CAPSULE WHITE NVR R20

16 HOW SUPPLIED/STORAGE AND HANDLING • 10 mg extended-release capsules (NDC 0078-0424-05) white/light brown, (imprinted “NVR R10”) supplied in bottles of 100 • 20 mg extended-release capsules (NDC 0078-0370-05) white, (imprinted “NVR R20”) supplied in bottles of 100 • 30 mg extended-release capsules (NDC 0078-0371-05) yellow, (imprinted “NVR R30”) supplied in bottles of 100 • 40 mg extended-release capsules (NDC 0078-0372-05) light brown, (imprinted “NVR R40”) supplied in bottles of 100 Store at 20°C to 25°C (68°F to 77°F); excursions permitted between 15°C and 30°C (59°F and 86°F) [See USP controlled room temperature]. Dispense in tight container (USP).

More pills like CAPSULE NVR R20

DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site

ritalin la methylphenidate hydrochloride capsule extended release

FDA Reported Adverse Reactions [1] fatigue [2] drug ineffective [3] nausea [4] dyspnoea [5] diarrhoea [6] pain [7] off label use [8] headache [9] dizziness [10] arthralgia

CAPSULE WHITE NVR R20

More pills like CAPSULE NVR R20

FDA Reported Adverse Reactions
`[1] fatigue` `[2] drug ineffective` `[3] nausea` `[4] dyspnoea` `[5] diarrhoea` `[6] pain` `[7] off label use` `[8] headache` `[9] dizziness` `[10] arthralgia`